| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $758.7M | +5.5% |
| Cost of Revenue | $87.0M | -9.4% |
| Gross Profit | $671.7M | +7.8% |
| R&D Expense | $100.2M | +8.5% |
| SG&A Expense | $123.7M | -17.2% |
| Operating Income | $150.4M | +118.3% |
| Pre-tax Income | $34.1M | +103.8% |
| Income Tax | $43.2M | +102.2% |
| Net Income | -$9.1M | +99.0% |
| EPS (Basic) | -$0.06 | +99.0% |
| EPS (Diluted) | -$0.06 | +99.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $284.7M | +133.9% |
| Accounts Receivable | $103.5M | +3.2% |
| Current Assets | $421.3M | +37.1% |
| Total Assets | $3.25B | +1.6% |
| Current Liabilities | $468.8M | +2.7% |
| Long-term Debt | $1.20B | +0.1% |
| Total Liabilities | $1.81B | -1.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $4.4M | -41.7% |
| Stockholders' Equity |
| $1.44B |
| +5.3% |